Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest cell therapy Stories

2014-04-15 08:30:55

SAN BRUNO, Calif., April 15, 2014 /PRNewswire/ -- Cord Blood Registry® (CBR®) announces the launch of an FDA-regulated clinical trial being conducted at The University of Texas Health Science Center at Houston to investigate two forms of stem cell therapy in children diagnosed with cerebral palsy. The randomized, placebo-controlled study aims to compare the safety and efficacy of an intravenous infusion of cord blood stem cells to bone marrow stem cells....

2014-04-11 13:01:17

Significant new data presented today at the International Liver Congress™ 2014 indicate that liver cancer (Hepatocellular Carcinoma (HCC)) may be treated by adoptive T-cell therapy. This new therapeutic approach in the treatment of HCC could be very important as without treatment the 5 year survival rate is just 5%. Globally, HCC accounts for 746,000 deaths, and in the UK alone is responsible for over 4,000 deaths per year. Glypican-3 (GPC3) is a tumor associated antigen expressed in...

2014-04-11 12:23:51

DUBLIN, Apr. 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/qsm3wn/cord_blood ) has announced the addition of the "Cord Blood Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Stem cells are capable of producing all the three types of blood cells produced in human body i.e. red blood cells, platelets and white...

2014-04-08 12:30:51

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fv78n3/cardiovascular) has announced the addition of a new report "Cardiovascular Drug Delivery - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/fv78n3/cardiovascular ] to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Drug delivery to the cardiovascular system is different from...

2014-04-08 08:32:20

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/492nrm/gene_therapy) has announced the addition of a new report "Gene Therapy - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/492nrm/gene_therapy ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Gene therapy can be broadly defined as the transfer of defined genetic material to specific target...

2014-04-08 08:30:44

ST. LOUIS, April 8, 2014 /PRNewswire/ -- ISTO Technologies, Inc. ("ISTO," the "Company"), a privately-held regenerative medicine company applying its proprietary platform technologies to orthopedic and spine applications, has appointed Phillip W. Kuhn, a medical technology executive with over three decades of industry experience, as the Company's Chief Commercial Officer. In this newly created role, Mr. Kuhn will oversee ISTO's commercial strategy, including the execution of...

2014-04-07 08:32:26

Will Also Present Update on Ongoing Phase II Trial ROCKVILLE, Md., April 7, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Eva Feldman, PhD, MD, principal investigator of Neuralstem's NSI-566 stem cell trial in ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease) will present Phase I data at the Keystone Symposia, "Engineering Cell Fate and Function," in Olympic Valley, California, on April 9(th...

2014-04-07 08:32:15

Members committed to the standardization of cell therapies, regenerative medicine drugs and other biologics. LARKSPUR, Calif., April 7, 2014 /PRNewswire/ -- Today BioCision, LLC, a leader in advanced temperature management technologies that standardize biomaterial handling, announced the establishment of the company's first advisory board. Lori Kunkel, MD, former chief medical officer at Pharmacyclics, Inc., will serve as chair of the board, and will be joined by Scott Burger, MD,...

2014-04-04 23:41:39

Dr. Jeffrey Adler of Adler Footcare New York will discuss stem cell replacement therapy, a new treatment option available to treat painful foot problems, on NewsTalkRadio 77 WABC in New York City on April 5. New York, New York (PRWEB) April 03, 2014 Dr. Jeffrey Adler, New York podiatrist and Owner/Medical Director of Adler Footcare New York, will be interviewed by radio personality Laura Smith and taking live calls on New York talk show 77 WABC about the use of stem cells to treat...

2014-04-02 08:32:13

Autologous Cells Modified with Licensed T Cell Receptor (TCR) IP from University of Pennsylvania Studied for Safety, Bioactivity, and Effectiveness to Treat Multiple Myeloma BOTHELL, Wash., April 2, 2014 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today announced that Oxford, UK...